FDA panel approves COVID booster plan for elderly, high-risk – Los Angeles Times

An influential federal advisory panel has overwhelmingly rejected a plan to give booster shots of Pfizer’s COVID-19 vaccine to most Americans, but it endorsed the extra shots for those who are 65 or older or run a high risk of severe disease…

The FDA advisory panel was the first major hurdle that the Biden administration plan faced. The FDA itself has yet to make its own determination but typically follows the recommendations of its expert panel.

In yet another step to the process, a CDC advisory committee that sets policy for U.S. vaccinations campaigns is set meet on Wednesday to debate who, exactly, should get boosters and how many months after their second dose should them receive the extra shot.

The CDC has said it is considering boosters for older people, nursing home residents and front-line health care workers, rather than all adults.

Source: FDA panel approves COVID booster plan for elderly, high-risk – Los Angeles Times